Indian Pharma Post

Delhi, India
News and insights platform for the pharmaceutical industry in India.

About Indian Pharma Post

Indian Pharma Post is a Healthcare company based in Delhi (India). News and insights platform for the pharmaceutical industry in India. Its Indian entity Sindhu Media Private Limited reported revenue of β‚Ή2.30 Cr. Indian Pharma Post offers products and services including News and Insights and Newsletters. Its focus areas include Biotech, Drug Approvals, Regulatory Updates and Pharmaceuticals.

Company details

Indian Pharma Post is operated as an online platform that delivers news and insights on the pharmaceutical industry, with reports on the latest updates, drug discoveries, and research being compiled from various sources. Emphasis is placed on trending topics within the healthcare sector, including policy developments and best practices across the industry spectrum. A team of experts is utilized to provide insights on policies that influence industry growth, ensuring coverage of drug approvals, supply chains, and sustainability efforts. This platform is accessed for its role in highlighting critical advancements and fostering awareness in the field.

  • Headquarters Delhi, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Social LinkedIn Facebook YouTube
  • Legal Name Sindhu Media Pvt Ltd
  • Date of Incorporation 21 Dec, 2016
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹2.30 Cr

    FY 2025 · +38% YoY

  • Net Profit
    ₹11.1 Lakh

    FY 2025 · 5% margin

  • EBITDA
    ₹16.2 Lakh

    FY 2025 · 7% margin

Products & Services of Indian Pharma Post

Indian Pharma Post offers a comprehensive portfolio of products and services, including News and Insights and Newsletters.

News and Insights
Information Services

News on the pharmaceutical industry is delivered through an online platform

Newsletters
Subscription Services

Daily updates on industry news are provided via email subscriptions

Apps and channels of Indian Pharma Post

its YouTube channel Indian Pharma Post has 2 subscribers.

Indian Pharma Post
YouTube 2 subscribers Other
Open channel

Board of directors of Sindhu Media Private Limited (Indian Pharma Post)

Sindhu Media Private Limited is the primary company behind Indian Pharma Post. The board of Sindhu Media Private Limited currently have 3 directors; the longest-serving is Yogesh Joshi, appointed in 2016. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Yogesh Joshi
DIN 07677542
Director21 Dec 20169 yrs 10 moSindhu Media Private Limited
Pravin Prashant
DIN 01658587
Director21 Dec 20169 yrs 10 moSindhu Media Private Limited
Murari Mohan Jha
DIN 09755793
Director25 Jun 20242 yrs 3 moSindhu Media Private Limited

Financials of Indian Pharma Post

Figures of Sindhu Media Private Limited, the primary company behind Indian Pharma Post, for FY 2025. Revenue was ₹2.30 Cr (+38% year on year). Net profit was ₹11.1 Lakh (5% margin). EBITDA was ₹16.2 Lakh (7% margin). Revenue has grown at a compounded annual rate of +25% over three years and +47% over five years.

  • ₹2.30 CrRevenue · FY 2025 · +38% YoY
  • ₹11.1 LakhNet profit · 5% margin
  • ₹16.2 LakhEBITDA · 7% margin
  • ₹1 LakhPaid-up capital
  • +25%Revenue CAGR, 3 years
  • +47%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sindhu Media Private Limited are on its company page.

Premium access

Detailed financial statements for Indian Pharma Post

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Indian Pharma Post

Websites that share an audience with Indian Pharma Post (indianpharmapost.com).

Similar websites

Websites whose visitors overlap most with Indian Pharma Post. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
zyduslife.com
82%
48.1K#726,817View details
themedicinemaker.com
79%
8.1K#2,851,127View details
biocon.com
72%
82.3K#297,196View details
citeline.com
70%
127.1K#291,889View details
globelapharma.com
67%
5.6K#2,737,199View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 8 similar websites and full traffic analytics for Indian Pharma Post

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical Trials & Research Tech

2 companies that operate in the same segment as Indian Pharma Post (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, IndiaUSD 50.52 M902
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, IndiaUSD 4.22 M228
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Indian Pharma Post

Indian Pharma Post is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

The primary company behind Indian Pharma Post, Sindhu Media Private Limited, reported revenue of β‚Ή2.30 Cr for FY 2025, up 38% year on year.

Indian Pharma Post is operated as an online platform that delivers news and insights on the pharmaceutical industry, with reports on the latest updates, drug discoveries, and research being compiled from various sources. Emphasis is placed on trending topics within the healthcare sector, including policy developments and best practices across the industry spectrum. A team of experts is utilized to provide insights on policies that influence industry growth, ensuring coverage of drug approvals, supply chains, and sustainability efforts. This platform is accessed for its role in highlighting critical advancements and fostering awareness in the field.

Indian Pharma Post offers News and Insights and Newsletters.

Indian Pharma Post operates through Sindhu Media Private Limited.

The legal entities of Indian Pharma Post currently have 3 directors, including Yogesh Joshi, Murari Mohan Jha, Pravin Prashant.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available